Companies › EWTX

EDGEWISE THERAPEUTICS INC (EWTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001710072 · EDGAR filings · Updated 2026-07-17

EDGEWISE THERAPEUTICS INC (EWTX) has reported institutional ownership of 110.2%, with 214 institutional managers holding positions valued at $3.72B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-16 — Amended current report (8-K/A) filed
• 2026-07-13 — Current report (8-K) filed
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-07-01 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EDGEWISE THERAPEUTICS INC has 214 institutional holders and institutional ownership of 110.2%.

Insider activity

Insiders reported 51 transactions (5 buys, 22 sells) across 10 reporting insiders, with a net reported value of $11.5M.

Data flags from SEC filings

Related companies

INDIVIOR PHARMACEUTICALS INC (INDV) · TANGO THERAPEUTICS INC (TNGX) · LIVANOVA PLC SHS (LIVN) · CRISPR THERAPEUTICS AG (CRSP) · ACADIA PHARMACEUTICALS INC COM (ACAD) · TWIST BIOSCIENCE CORP (TWST)